1. GPCR/G Protein
  2. Vasopressin Receptor
  3. V1a/V2 antagonist 1

V1a/V2 antagonist 1 (Compound 18j) is an orally active dual V1a and V2 receptor antagonist with high binding affinity for both receptors (Ki: 0.13 nM for hV1a, 0.53 nM for hV2 and 0.5 nM for mV1a; IC50: 2.2 nM for hV1a). V1a/V2 antagonist 1 inhibits Oxytocin (HY-17571)-induced scratching behavior in mice.

For research use only. We do not sell to patients.

V1a/V2 antagonist 1 Chemical Structure

V1a/V2 antagonist 1 Chemical Structure

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  
Synthetic products have potential research and development risk.

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Top Publications Citing Use of Products

View All Vasopressin Receptor Isoform Specific Products:

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

V1a/V2 antagonist 1 (Compound 18j) is an orally active dual V1a and V2 receptor antagonist with high binding affinity for both receptors (Ki: 0.13 nM for hV1a, 0.53 nM for hV2 and 0.5 nM for mV1a; IC50: 2.2 nM for hV1a). V1a/V2 antagonist 1 inhibits Oxytocin (HY-17571)-induced scratching behavior in mice[1].

IC50 & Target[1]

human V1a Receptor

0.13 nM (Ki)

human V2 Receptor

0.53 nM (Ki)

human V1a Receptor

2.2 nM (IC50)

In Vitro

V1a/V2 antagonist 1 (1 μM) exhibits good hepatic microsomal metabolic stability, with Clint (h/r/m) (μL/min/mg) of 15.9/36.9/ 27.1[1].
V1a/V2 antagonist 1 has no interaction with hERG (IC50: >30 μM), and shows PDR value of 0.91 (VB-Caco-2 permeability assay)[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

V1a/V2 antagonist 1 (0.1-3 mg/kg, p.o., 60-min pretreatment) notably inhibits Oxytocin (HY-17571)-induced scratching behavior in mice[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: OT-induced scratching in mice [1]
Dosage: 0.1, 0.3, 1, 3 mg/kg
Administration: Oral gavage (p.o.), 60-min pretreatment
Result: Inhibited scratching with inhibition rate of 86% (3 mg/kg), 91% (1 mg/kg), 85% (0.3 mg/kg) and 81% (0.1 mg/kg).
Molecular Weight

479.96

Formula

C25H26ClN5O3

SMILES

ClC1=CC=C2N3C(N(CC4)CCN4C5=C(OCC6)C6=CC=C5)=NN=C3CC7(OCCO7)CC2=C1

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

V1a/V2 antagonist 1 Related Classifications

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Salutation

Applicant Name *

 

Email Address *

Phone Number *

 

Organization Name *

Department *

 

Requested quantity *

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
V1a/V2 antagonist 1
Cat. No.:
HY-168742
Quantity:
MCE Japan Authorized Agent: